ScreenerHero

0KCC Insight Molecular Diagnostics Inc.

LSE · GB · Healthcare · Biotechnology · imdxinc.com
3.750USD+16.46%Mkt Cap: —P/E: —

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value107.59M USD
Revenue (TTM)1.67M USD
Gross Profit814.00K USD
Net Income (TTM)-49.36M USD
Revenue/Share0.05 USD
Last Price3.750 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.12
EV/Revenue64.42
P/S—
P/B-5.36
EPS (TTM)-0.77
EPS (Forward)—
52W Range
1.91831% of range7.770
52W High7.770 USD
52W Low1.918 USD
Profitability
Gross Margin48.74%
Oper. Margin-3815.06%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-57.82%
Growth
Revenue Growth-53.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.08M USD
CapEx (TTM)—
FCF Margin-1125.12%
FCF Yield—
Net Debt-15.13M USD
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity—
Current Ratio2.00
Quick Ratio1.75
Book Value/Sh-0.65 USD
Cash/Share0.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.05:1
Split DateJul 25, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.66M
Float9.98M
Insiders21.00%
Institutions56.43%
Technical
SMA 501.768 (+112.1%)
SMA 2001.768 (+112.1%)
Beta1.80
S&P 52W Chg15.78%
Avg Vol (30d)634
Avg Vol (10d)410
Technical Indicators
RSI (14)46.3
MACD-0.3110
MACD Signal-0.3227
MACD Hist.+0.0118
BB Upper4.452 USD
BB Middle3.806 USD
BB Lower3.160 USD
BB Width33.94%
ATR (14)0.2772 USD
Vol Ratio (20d)0.31x